Dose-Volume Factors Analysis for Radiation-Induced Hepatic Toxicity in Patients with Hepatocellular Carcinoma after Radiotherapy

Dose-Volume Factors Analysis for Radiation-Induced Hepatic Toxicity in Patients with Hepatocellular Carcinoma after Radiotherapy

碩士 === 國立高雄科技大學 === 電子工程系 === 107 === Purpose : To assess the dose-volume factors analysis of radiation - induced hepatic toxicity (RIHT) in patients with hepatocellular carcinoma (HCC) after radiotherapy. Materials and methods : The study is retrospectively collected between 2014 and 2017, 114 pati...

Full description

Bibliographic Details
Main Authors:	LU,WEI-HAN, 呂維翰
Other Authors:	Tsair-Fwu Lee
Format:	Others
Language:	zh-TW
Published:	2019
Online Access:	http://ndltd.ncl.edu.tw/handle/pan373

Similar Items

Relationship Between Heart Irradiation Dose-volume and Radiation-induced Cardiac Toxicity in Radiotherapy for Thoracic Neoplasms
by: LI Huan, et al.
Published: (2018-11-01)

Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
by: Jing Liu, et al.
Published: (2017-05-01)

Radiation-induced late dysphagia after intensity-modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume effect analysis
by: Li Jiang, et al.
Published: (2018-11-01)

Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity
by: Liang P, et al.
Published: (2016-11-01)

Dose-volume analysis of predictors for acute anal toxicity after radiotherapy in prostate cancer patients
by: Xingsi Peng, et al.
Published: (2019-10-01)

A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis
by: Cheng-Yun Yao, et al.
Published: (2018-10-01)

Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination
by: Luis A. Pérez-Romasanta, et al.
Published: (2021-01-01)

Correlations between Radiation Dose and Reconstructed Volume Error with Computed Tomography Simulation
by: Yen, Wei-Han, et al.
Published: (2017)

Analysis of association between dose -volume parameters and radiation-induced brain edema in patients with Brain tumor after stereotactic radiotherapy
by: LIU,SHIH-PEI, et al.
Published: (2019)

Prednisolone combined with hyperbaric oxygen used to control radiation-induced gastritis after radiotherapy for hepatocellular carcinoma: a case report
by: ZHANG Ying
Published: (2018-02-01)

Radiotherapy dose–volume parameters predict facial lymphedema after concurrent chemoradiation for nasopharyngeal carcinoma
by: Donghyun Kim, et al.
Published: (2021-09-01)

Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma
by: Lie-Qiang Liao, et al.
Published: (2016-10-01)

Biophysical Analysis of Acute and Late Toxicity of Radiotherapy in Gastric Marginal Zone Lymphoma—Impact of Radiation Dose and Planning Target Volume
by: Gabriele Reinartz, et al.
Published: (2021-03-01)

Phase I Radiation Dose-Escalation Study to Investigate the Dose-Limiting Toxicity of Concurrent Intra-Arterial Chemotherapy for Unresectable Hepatocellular Carcinoma
by: Yeona Cho, et al.
Published: (2020-06-01)

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy
by: De B, et al.
Published: (2021-03-01)

Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: A multicenter study.
by: Baek Gyu Jun, et al.
Published: (2018-01-01)

Radiation-induced abnormal cortical thickness in patients with nasopharyngeal carcinoma after radiotherapy
by: Jiabao Lin, et al.
Published: (2017-01-01)

Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose.
by: Yoo-Kang Kwak, et al.
Published: (2017-01-01)

Vinorelbine Augments Radiotherapy in Hepatocellular Carcinoma
by: Kheng Wei Yeoh, et al.
Published: (2020-04-01)

Radiotherapy for metastatic fibrolamellar hepatocellular carcinoma
by: Justin G. Peacock, et al.
Published: (2013-07-01)

Strategic application of radiotherapy for hepatocellular carcinoma
by: Seo Hee Choi, et al.
Published: (2018-06-01)

Hepatitis C virus-induced hepatocellular carcinoma
by: Nicolas Goossens, et al.
Published: (2015-06-01)

The effects of fenugreek on radiation induced toxicity for human blood T-cells in radiotherapy
by: Mohamed Bagher Tavakoli, et al.
Published: (2015-01-01)

Correlation Between Dose Volume Parameters and Radiation Pneumonitis in Elderly Patients with Esophageal Cancer After Three-dimensional Conformal Radiotherapy
by: WANG Sheng, et al.
Published: (2021-02-01)

Persistence of Hepatocellular Carcinoma Risk after Hepatitis C Virus Eradication
by: Sojung Han, et al.
Published: (2020-05-01)

A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy
by: Rashmi Jadon, et al.
Published: (2019-04-01)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.
by: Sebastian Zschaeck, et al.
Published: (2017-01-01)

Uniformity of Dose Distribution in Target Volume in Radiotherapy Techniques for Breast after Mastectomy.
by: Sajad Pashton shayesteh, et al.
Published: (2014-03-01)

Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma
by: Abousaida B, et al.
Published: (2021-09-01)

ASSESSMENT OF THE EFFICACY OF DOSE RADIATION THERAPY REGIMENS FOR TREATING CANCER ACCORDING TO CRITERIA FOR EARLY TOXICITY OF RADIOTHERAPY
by: V. A. Lisin
Published: (2018-05-01)

Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma.
by: Olivier Mir, et al.
Published: (2012-01-01)

Thyroid dose‐volume thresholds for the risk of radiation‐related hypothyroidism in nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy—A single‐institution study
by: Cheng‐Long Huang, et al.
Published: (2019-11-01)

Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy
by: Flatmark Kjersti, et al.
Published: (2011-04-01)

Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization
by: Erhua Yao, et al.
Published: (2018-01-01)

Comparison of three‐dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus
by: Fang Su, et al.
Published: (2018-09-01)

Dose Volume Relationship in Estimating Cardiac Doses in Breast Cancer Radiotherapy
by: Lucy Pattanayak, et al.
Published: (2020-11-01)

Risk of hepatocellular carcinoma after hepatitis C virus cure
by: Ali, M.J, et al.
Published: (2022)

Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy.
by: Cheng-Hsiang Lo, et al.
Published: (2017-01-01)

Pattern of radiation-induced thyroid gland changes in nasopharyngeal carcinoma patients in 48 months after radiotherapy.
by: Zhixiong Lin, et al.
Published: (2018-01-01)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
by: David Thomson, et al.
Published: (2012-01-01)